Literature DB >> 8764936

Expression of CD44 isoforms in human renal cell carcinomas.

K H Heider1, M Ratschek, K Zatloukal, G R Adolf.   

Abstract

A series of 27 renal cell carcinomas 4 oncocytomas and 7 samples of tumour free kidney parenchyma were analysed immunohistochemically using eight different CD44 isoform-specific monoclonal antibodies. In normal kidney expression of CD44 isoforms (containing variant exons v6, v7/8 and v10) was found predominantly at the distal tubules. The majority of clear cell carcinomas investigated showed expression of variant exons v5, v7/8 and v10, but not v6. Lack of CD44v6 expression was confirmed by reverse transcription-polymerase chain reaction analysis. Carcinomas of the chromophilic cell type were almost completely devoid of CD44 expression, including the standard form CD44s. This study shows that there are statistically significant differences in the CD44 expression pattern of the two major histological subtypes of renal cell carcinomas (clear cell and chromophilic carcinomas). Moreover, the almost complete lack of CD44 expression in chromophilic carcinomas contrasts with carcinomas of other histogenetic origin investigated including stomach, breast and lung which express various CD44 isoforms abundantly.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8764936     DOI: 10.1007/bf00196700

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  23 in total

1.  Identification of the 37-kDa protein displaying a variable interaction with the erythroid cell membrane as glyceraldehyde-3-phosphate dehydrogenase.

Authors:  R W Allen; K A Trach; J A Hoch
Journal:  J Biol Chem       Date:  1987-01-15       Impact factor: 5.157

2.  Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa.

Authors:  K H Heider; J Dämmrich; P Skroch-Angel; H K Müller-Hermelink; H P Vollmers; P Herrlich; H Ponta
Journal:  Cancer Res       Date:  1993-09-15       Impact factor: 12.701

3.  Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics.

Authors:  W Thoenes; S Störkel; H J Rumpelt
Journal:  Pathol Res Pract       Date:  1986-05       Impact factor: 3.250

4.  Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.

Authors:  G R Screaton; M V Bell; D G Jackson; F B Cornelis; U Gerth; J I Bell
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

5.  Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium.

Authors:  P Dall; K H Heider; A Hekele; G von Minckwitz; M Kaufmann; H Ponta; P Herrlich
Journal:  Cancer Res       Date:  1994-07-01       Impact factor: 12.701

6.  Prevention of tumor metastasis formation by anti-variant CD44.

Authors:  S Seiter; R Arch; S Reber; D Komitowski; M Hofmann; H Ponta; P Herrlich; S Matzku; M Zöller
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

7.  The expression of variant CD44 in nasopharyngeal carcinoma is unrelated to expression of LMP-1.

Authors:  L Brooks; G Niedobitek; A Agathanggelou; P J Farrell
Journal:  Am J Pathol       Date:  1995-05       Impact factor: 4.307

8.  CD44 variant exon epitopes in primary breast cancer and length of survival.

Authors:  M Kaufmann; K H Heider; H P Sinn; G von Minckwitz; H Ponta; P Herrlich
Journal:  Lancet       Date:  1995-03-11       Impact factor: 79.321

9.  CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor.

Authors:  R Stauder; W Eisterer; J Thaler; U Günthert
Journal:  Blood       Date:  1995-05-15       Impact factor: 22.113

10.  A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps.

Authors:  K H Heider; M Hofmann; E Hors; F van den Berg; H Ponta; P Herrlich; S T Pals
Journal:  J Cell Biol       Date:  1993-01       Impact factor: 10.539

View more
  4 in total

1.  Expression of osteopontin and CD44 molecule in papillary renal cell tumors.

Authors:  Koviljka Matusan; Gordana Dordevic; Vladimir Mozetic; Ksenija Lucin
Journal:  Pathol Oncol Res       Date:  2005-07-01       Impact factor: 3.201

2.  Up-regulation of the tumour-associated marker CD44V6 in experimental kidney disease.

Authors:  K Takazoe; R Foti; G H Tesch; L A Hurst; H Y Lan; R C Atkins; D J Nikolic-Paterson
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

3.  CD44 is associated with tumor recurrence and is an independent poor prognostic factor for patients with localized clear cell renal cell carcinoma after nephrectomy.

Authors:  Byung-Joo Jeong; Zhe Long Liang; Song Mei Huang; Jae Sung Lim; Jin Man Kim; Hyo Jin Lee
Journal:  Exp Ther Med       Date:  2012-03-05       Impact factor: 2.447

4.  Cell surface antigens in renal tumour cells: detection by immunoluminescence and enzymatic analysis.

Authors:  F Laube; B Göhring; H Sann; I Willhardt
Journal:  Br J Cancer       Date:  2001-09-14       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.